Want to see SE:ITECH full AI Analyst Report?
Top Page
I-Tech AB
(ITECH)
Select Model
Select Model
Rating:79Outperform
Price Target:
kr85.00
▲(57.99% Upside)
Action:Reiterated
Date:08/22/26
The score is driven primarily by strong financial quality—debt-free balance sheet, solid profitability, and strong cash conversion—supported by a clear uptrend in technicals. These positives are tempered by a less attractive valuation (P/E ~25.5 with a modest ~1.69% yield) and some historical volatility in revenue/gross margins.
Positive Factors
Profitable growth
Recent growth combined with strong profitability indicates effective commercialization and operating leverage. If sustained, this earnings base can support reinvestment and widen the company’s ability to scale Selektope adoption.
Negative Factors
Revenue and margin volatility
The weaker 2025 revenue and gross-margin profile shows that earnings may remain sensitive to customer mix, pricing and costs. Such variability can make future profitability less predictable even while the recent TTM performance remains strong.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitable growth
Recent growth combined with strong profitability indicates effective commercialization and operating leverage. If sustained, this earnings base can support reinvestment and widen the company’s ability to scale Selektope adoption.
Read all positive factors
I-Tech AB (ITECH) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr926.23M
Dividend Yield1.6%
Average Volume (3M)30.18K
Price to Earnings (P/E)19.3
Beta (1Y)-0.17
Revenue Growth2.13%
EPS Growth22.09%
CountrySE
Employees11
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)4.05
Shares Outstanding11,997,777
10 Day Avg. Volume43,174
30 Day Avg. Volume30,179
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)3.58
Price to Sales (P/S)3.71
P/FCF Ratio9.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.21
Revenue Forecast (FY)kr202.00M
I-Tech AB Business Overview & Revenue Model
Company Description
I-Tech AB, a biotechnology firm established in Mölndal, Sweden, in 2000, focuses on creating and commercializing products to prevent biofouling. Their flagship innovation is Selektope, a unique bio-repellent ingredient engineered for marine coatin...
How the Company Makes Money
I-Tech AB makes money primarily by commercializing Selektope® as an active ingredient for use in antifouling paint and coating formulations. Revenue is generated through sales of Selektope® to coating manufacturers and/or through licensing-type ar...
I-Tech AB Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
86
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 191.03M | 168.12M | 179.45M | 120.86M | 83.63M | 52.90M |
| Gross Profit | 49.79M | 47.43M | 95.22M | 63.54M | 45.13M | 27.48M |
| EBITDA | 68.31M | 49.74M | 54.31M | 30.34M | 18.06M | 1.60M |
| Net Income | 48.61M | 33.19M | 39.01M | 20.20M | 10.62M | -2.65M |
Balance Sheet | ||||||
| Total Assets | 223.52M | 193.73M | 173.11M | 152.44M | 125.41M | 115.12M |
| Cash, Cash Equivalents and Short-Term Investments | 165.40M | 148.16M | 100.16M | 83.26M | 52.75M | 35.01M |
| Total Debt | 0.00 | 0.00 | 7.79M | 0.00 | 2.25M | 4.29M |
| Total Liabilities | 30.59M | 19.35M | 15.73M | 16.20M | 9.37M | 10.19M |
| Stockholders Equity | 192.93M | 174.39M | 157.39M | 136.24M | 116.03M | 104.94M |
Cash Flow | ||||||
| Free Cash Flow | 67.03M | 64.51M | 35.04M | 32.76M | 20.06M | -2.43M |
| Operating Cash Flow | 68.56M | 64.60M | 35.17M | 35.14M | 20.13M | -1.70M |
| Investing Cash Flow | -1.53M | -409.00K | -408.00K | -2.38M | -822.00K | -928.00K |
| Financing Cash Flow | -14.28M | -16.20M | -17.86M | -2.25M | -1.56M | -3.35M |
I-Tech AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | kr926.23M | 19.31 | ― | 3.31% | 2.13% | 22.09% | |
69 Neutral | kr27.10M | 8.98 | ― | ― | -17.14% | 88.76% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | kr149.76M | 54.98 | 1.04% | 2.89% | -14.23% | 84.80% | |
49 Neutral | kr427.28M | -33.30 | ― | ― | 54.37% | 52.22% | |
46 Neutral | kr436.92M | -9.76 | ― | ― | 3.26% | 16.82% | |
43 Neutral | kr69.07M | -1.36 | -166.81% | ― | -21.95% | -28.77% |
* General Sector Average
SE:ITECH
I-Tech AB
78.20
-10.07
-11.40%
SE:POLYG
Polygiene AB
4.42
-4.34
-49.52%
SE:ORGC
OrganoClick AB
0.41
-1.43
-77.66%
SE:ENZY
Enzymatica AB
1.81
-0.59
-24.58%
SE:CLBIO
Corline Biomedical AB
16.40
3.45
26.64%
SE:PCAT
Photocat A/S
5.20
-2.80
-35.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.